Microlin Bio Inc. (formerly American Boarding Co.) is a development stage emerging therapeutic company focusing on microRNA and its role in oncology. We are working to develop and market, antimiR therapies and miR replacement therapies. Our ultimate goal is to change the field of cancer treatment, minimize unnecessary healthcare costs and improve patients’ quality of life. We are focused on four types of cancer: lung, ovarian, colorectal and prostate.
Company profile
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
American Boarding Co
SEC CIK
Corporate docs
Latest filings (excl ownership)
REVOKED
Registration or securities revoked
26 Apr 19
CT ORDER
Confidential treatment order
14 Jun 17
10-K
2015 FY
Annual report
27 May 16
NT 10-Q
Notice of late quarterly filing
17 May 16
8-K
Changes in Registrant's Certifying Accountant
26 Apr 16
8-K
Other Events
17 Mar 16
NT 10-Q
Notice of late quarterly filing
16 Feb 16
8-K
Microlin Bio Signs Exclusive License and Research Agreement with Université Laval to Develop microRNA-Based Treatments for Alzheimer’s Disease
10 Feb 16
8-K
Other Events
12 Jan 16
8-K
Changes in Registrant's Certifying Accountant
7 Jan 16
Latest ownership filings
3
Joseph Hernandez
12 Jan 16
3
JOHN N BONFIGLIO
8 Jan 16
4
Joseph Robert Marshall
24 Dec 15
4
Change in insider ownership
23 Dec 15
4
Reza Noorkayhani
23 Dec 15
4
Reza Noorkayhani
2 Dec 15
SC 13D
American Boarding Co
24 Nov 14
SC 13D
American Boarding Co
3 Nov 14
SC 13D
American Boarding Co
27 Oct 14
SC 13D
American Boarding Co
27 Oct 14